{"count": 14, "results": [{"_id": "34367059", "pmid": 34367059, "pmcid": "PMC8342037", "title": "Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit", "journal": "Front Endocrinol (Lausanne)", "authors": ["Ibrahim S", "Lowe JR", "Bramante CT", "Shah S", "Klatt NR", "Sherwood N", "Aronne L", "Puskarich M", "Tamariz L", "Palacio A", "Bomberg E", "Usher M", "King S", "Benson B", "Vojta D", "Tignanelli C", "Ingraham N"], "date": "2021-07-22T00:00:00Z", "doi": "10.3389/fendo.2021.587801", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "587801", "score": 50262.027, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ is the first-line medication for @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@, but it also has a long history of improved outcomes in @DISEASE_Communicable_Diseases @DISEASE_MESH:D003141 @@@infectious diseases@@@, such as @DISEASE_Influenza_Human @DISEASE_MESH:D007251 @@@influenza@@@, @<m>DISEASE_Hepatitis_C_Chronic</m> @DISEASE_MESH:D019698 @@@hepatitis C@@@, and in-vitro assays of zika. ", "citations": {"NLM": "Ibrahim S, Lowe JR, Bramante CT, Shah S, Klatt NR, Sherwood N, Aronne L, Puskarich M, Tamariz L, Palacio A, Bomberg E, Usher M, King S, Benson B, Vojta D, Tignanelli C, Ingraham N. Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit Front Endocrinol (Lausanne). 2021;12():587801. PMID: 34367059", "BibTeX": "@article{34367059, title={Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit}, author={Ibrahim S and Lowe JR and Bramante CT and Shah S and Klatt NR and Sherwood N and Aronne L and Puskarich M and Tamariz L and Palacio A and Bomberg E and Usher M and King S and Benson B and Vojta D and Tignanelli C and Ingraham N}, journal={Front Endocrinol (Lausanne)}, volume={12}, pages={587801}}"}}, {"_id": "36208843", "pmid": 36208843, "title": "Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.", "journal": "J Hepatol", "authors": ["Tsai PC", "Kuo HT", "Hung CH", "Tseng KC", "Lai HC", "Peng CY", "Wang JH", "Chen JJ", "Lee PL", "Chien RN", "Yang CC", "Lo GH", "Kao JH", "Liu CJ", "Liu CH", "Yan SL", "Bair MJ", "Lin CY", "Su WW", "Chu CH", "Chen CJ", "Tung SY", "Tai CM", "Lin CW", "Lo CC", "Cheng PN", "Chiu YC", "Wang CC", "Cheng JS", "Tsai WL", "Lin HC", "Huang YH", "Yeh ML", "Huang CF", "Hsieh MH", "Huang JF", "Dai CY", "Chung WL", "Chen CY", "Yu ML", "T-COACH Study Group"], "date": "2023-02-01T00:00:00Z", "doi": "10.1016/j.jhep.2022.09.019", "meta_date_publication": "2023 Feb", "meta_volume": "78", "meta_issue": "2", "meta_pages": "281-292", "score": 50256.84, "text_hl": "RESULTS: Of 7,249 individuals with @<m>DISEASE_Hepatitis_C_Chronic</m> @DISEASE_MESH:D019698 @@@CHC@@@ enrolled in the study, 781 (10.8%) had @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ and 647 (82.8%) were @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ users. ", "citations": {"NLM": "Tsai PC, Kuo HT, Hung CH, Tseng KC, Lai HC, Peng CY, Wang JH, Chen JJ, Lee PL, Chien RN, Yang CC, Lo GH, Kao JH, Liu CJ, Liu CH, Yan SL, Bair MJ, Lin CY, Su WW, Chu CH, Chen CJ, Tung SY, Tai CM, Lin CW, Lo CC, Cheng PN, Chiu YC, Wang CC, Cheng JS, Tsai WL, Lin HC, Huang YH, Yeh ML, Huang CF, Hsieh MH, Huang JF, Dai CY, Chung WL, Chen CY, Yu ML, T-COACH Study Group. Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan. J Hepatol. 2023 Feb;78(2):281-292. PMID: 36208843", "BibTeX": "@article{36208843, title={Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.}, author={Tsai PC and Kuo HT and Hung CH and Tseng KC and Lai HC and Peng CY and Wang JH and Chen JJ and Lee PL and Chien RN and Yang CC and Lo GH and Kao JH and Liu CJ and Liu CH and Yan SL and Bair MJ and Lin CY and Su WW and Chu CH and Chen CJ and Tung SY and Tai CM and Lin CW and Lo CC and Cheng PN and Chiu YC and Wang CC and Cheng JS and Tsai WL and Lin HC and Huang YH and Yeh ML and Huang CF and Hsieh MH and Huang JF and Dai CY and Chung WL and Chen CY and Yu ML and T-COACH Study Group}, journal={J Hepatol}, volume={78}, number={2}, pages={281-292}}"}}, {"_id": "38140692", "pmid": 38140692, "pmcid": "PMC10748230", "title": "Metformin and Hepatocellular Carcinoma Risk Reduction in Diabetic Patients with Chronic Hepatitis C: Fact or Fiction?", "journal": "Viruses", "authors": ["Sacco M", "Ribaldone DG", "Saracco GM"], "date": "2023-12-17T00:00:00Z", "doi": "10.3390/v15122451", "meta_date_publication": "2023 Dec 17", "meta_volume": "15", "meta_issue": "12", "meta_pages": "", "score": 50255.555, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @DISEASE_Carcinoma_Hepatocellular @DISEASE_MESH:D006528 @@@Hepatocellular Carcinoma@@@ Risk Reduction in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetic@@@ @SPECIES_9606 @@@Patients@@@ with @<m>DISEASE_Hepatitis_C_Chronic</m> @DISEASE_MESH:D019698 @@@Chronic Hepatitis C@@@: Fact or Fiction?", "citations": {"NLM": "Sacco M, Ribaldone DG, Saracco GM. Metformin and Hepatocellular Carcinoma Risk Reduction in Diabetic Patients with Chronic Hepatitis C: Fact or Fiction? Viruses. 2023 Dec 17;15(12):. PMID: 38140692", "BibTeX": "@article{38140692, title={Metformin and Hepatocellular Carcinoma Risk Reduction in Diabetic Patients with Chronic Hepatitis C: Fact or Fiction?}, author={Sacco M and Ribaldone DG and Saracco GM}, journal={Viruses}, volume={15}, number={12}}"}}, {"_id": "20198629", "pmid": 20198629, "title": "Metformin improves sustained virologic response in difficult-to-cure hepatitis C: more questions than answers.", "journal": "Hepatology", "authors": ["Wang CC", "Kao JH"], "date": "2010-03-01T00:00:00Z", "doi": "10.1002/hep.23546", "meta_date_publication": "2010 Mar", "meta_volume": "51", "meta_issue": "3", "meta_pages": "1082; author reply 1082-3", "score": 50063.19, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ improves sustained virologic response in difficult-to-cure @<m>DISEASE_Hepatitis_C_Chronic</m> @DISEASE_MESH:D019698 @@@hepatitis C@@@: more questions than answers.", "citations": {"NLM": "Wang CC, Kao JH. Metformin improves sustained virologic response in difficult-to-cure hepatitis C: more questions than answers. Hepatology. 2010 Mar;51(3):1082; author reply 1082-3. PMID: 20198629", "BibTeX": "@article{20198629, title={Metformin improves sustained virologic response in difficult-to-cure hepatitis C: more questions than answers.}, author={Wang CC and Kao JH}, journal={Hepatology}, volume={51}, number={3}, pages={1082; author reply 1082-3}}"}}, {"_id": "19918969", "pmid": 19918969, "title": "Metformin in chronic hepatitis C virus hepatitis: caution needed with sex-based subgroup analysis.", "journal": "Hepatology", "authors": ["Geroldi D", "Emanuele E"], "date": "2010-02-01T00:00:00Z", "doi": "10.1002/hep.23360", "meta_date_publication": "2010 Feb", "meta_volume": "51", "meta_issue": "2", "meta_pages": "719", "score": 50061.625, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @<m>DISEASE_Hepatitis_C_Chronic</m> @DISEASE_MESH:D019698 @@@chronic hepatitis C virus hepatitis@@@: caution needed with sex-based subgroup analysis.", "citations": {"NLM": "Geroldi D, Emanuele E. Metformin in chronic hepatitis C virus hepatitis: caution needed with sex-based subgroup analysis. Hepatology. 2010 Feb;51(2):719. PMID: 19918969", "BibTeX": "@article{19918969, title={Metformin in chronic hepatitis C virus hepatitis: caution needed with sex-based subgroup analysis.}, author={Geroldi D and Emanuele E}, journal={Hepatology}, volume={51}, number={2}, pages={719}}"}}, {"_id": "24259699", "pmid": 24259699, "title": "Safety and efficacy of metformin in patients with type 2 diabetes mellitus and chronic hepatitis C.", "journal": "Ann Pharmacother", "authors": ["Harris K", "Smith L"], "date": "2013-10-01T00:00:00Z", "doi": "10.1177/1060028013503108", "meta_date_publication": "2013 Oct", "meta_volume": "47", "meta_issue": "10", "meta_pages": "1348-52", "score": 50057.953, "text_hl": "Safety and efficacy of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ and @<m>DISEASE_Hepatitis_C_Chronic</m> @DISEASE_MESH:D019698 @@@chronic hepatitis C", "citations": {"NLM": "Harris K, Smith L. Safety and efficacy of metformin in patients with type 2 diabetes mellitus and chronic hepatitis C. Ann Pharmacother. 2013 Oct;47(10):1348-52. PMID: 24259699", "BibTeX": "@article{24259699, title={Safety and efficacy of metformin in patients with type 2 diabetes mellitus and chronic hepatitis C.}, author={Harris K and Smith L}, journal={Ann Pharmacother}, volume={47}, number={10}, pages={1348-52}}"}}, {"_id": "24829699", "pmid": 24829699, "pmcid": "PMC4005479", "title": "Efficacy of Adding Metformin to Pegylated Interferon and Ribavirin in Treatment Naive Patients with Chronic Hepatitis C: A Randomized Double-Blind Controlled Trial", "journal": "Middle East J Dig Dis", "authors": ["Sharifi AH", "Mohammadi M", "Fakharzadeh E", "Zamini H", "Zaer-Rezaee H", "Jabbari H", "Merat S"], "date": "2014-01-01T00:00:00Z", "meta_date_publication": "2014 Jan", "meta_volume": "6", "meta_issue": "1", "meta_pages": "13-7", "score": 50055.29, "text_hl": " A few researchers have investigated @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Hepatitis_C_Chronic</m> @DISEASE_MESH:D019698 @@@CHC@@@. ", "citations": {"NLM": "Sharifi AH, Mohammadi M, Fakharzadeh E, Zamini H, Zaer-Rezaee H, Jabbari H, Merat S. Efficacy of Adding Metformin to Pegylated Interferon and Ribavirin in Treatment Naive Patients with Chronic Hepatitis C: A Randomized Double-Blind Controlled Trial Middle East J Dig Dis. 2014 Jan;6(1):13-7. PMID: 24829699", "BibTeX": "@article{24829699, title={Efficacy of Adding Metformin to Pegylated Interferon and Ribavirin in Treatment Naive Patients with Chronic Hepatitis C: A Randomized Double-Blind Controlled Trial}, author={Sharifi AH and Mohammadi M and Fakharzadeh E and Zamini H and Zaer-Rezaee H and Jabbari H and Merat S}, journal={Middle East J Dig Dis}, volume={6}, number={1}, pages={13-7}}"}}, {"_id": "22486858", "pmid": 22486858, "title": "The effect of metformin on the efficacy of antiviral therapy in patients with genotype 1 chronic hepatitis C and insulin resistance.", "journal": "Int J Infect Dis", "authors": ["Yu JW", "Sun LJ", "Zhao YH", "Kang P", "Yan BZ"], "date": "2012-06-01T00:00:00Z", "doi": "10.1016/j.ijid.2012.02.004", "meta_date_publication": "2012 Jun", "meta_volume": "16", "meta_issue": "6", "meta_pages": "e436-41", "score": 50054.977, "text_hl": "The effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on the efficacy of antiviral therapy in @SPECIES_9606 @@@patients@@@ with genotype 1 @<m>DISEASE_Hepatitis_C_Chronic</m> @DISEASE_MESH:D019698 @@@chronic hepatitis C@@@ and @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@.", "citations": {"NLM": "Yu JW, Sun LJ, Zhao YH, Kang P, Yan BZ. The effect of metformin on the efficacy of antiviral therapy in patients with genotype 1 chronic hepatitis C and insulin resistance. Int J Infect Dis. 2012 Jun;16(6):e436-41. PMID: 22486858", "BibTeX": "@article{22486858, title={The effect of metformin on the efficacy of antiviral therapy in patients with genotype 1 chronic hepatitis C and insulin resistance.}, author={Yu JW and Sun LJ and Zhao YH and Kang P and Yan BZ}, journal={Int J Infect Dis}, volume={16}, number={6}, pages={e436-41}}"}}, {"_id": "20460925", "pmid": 20460925, "title": "Insulin resistance and response to antiviral therapy in chronic hepatitis C: mechanisms and management.", "journal": "Dig Dis", "authors": ["del Campo JA", "López RA", "Romero-Gómez M"], "date": "2010-01-01T00:00:00Z", "doi": "10.1159/000282104", "meta_date_publication": "2010", "meta_volume": "28", "meta_issue": "1", "meta_pages": "285-93", "score": 50053.016, "text_hl": "A recent controlled, randomized, double-blind clinical trial (TRIC-1) examined the effect of adding @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ to standard therapy in the treatment of @<m>DISEASE_Hepatitis_C_Chronic</m> @DISEASE_MESH:D019698 @@@hepatitis C.@@@ This study demonstrated that @SPECIES_9606 @@@women@@@ infected with @SPECIES_11103 @@@hepatitis C virus@@@ genotype 1 and HOMA >2 treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ showed a greater drop in viral load during the first 12 weeks and a doubled sustained viral response in comparison with females receiving placebo. ", "citations": {"NLM": "del Campo JA, López RA, Romero-Gómez M. Insulin resistance and response to antiviral therapy in chronic hepatitis C: mechanisms and management. Dig Dis. 2010;28(1):285-93. PMID: 20460925", "BibTeX": "@article{20460925, title={Insulin resistance and response to antiviral therapy in chronic hepatitis C: mechanisms and management.}, author={del Campo JA and López RA and Romero-Gómez M}, journal={Dig Dis}, volume={28}, number={1}, pages={285-93}}"}}, {"_id": "21199519", "pmid": 21199519, "title": "Hepatic steatosis and hepatitis C: Still unhappy bedfellows?", "journal": "J Gastroenterol Hepatol", "authors": ["Hwang SJ", "Lee SD"], "date": "2011-01-01T00:00:00Z", "doi": "10.1111/j.1440-1746.2010.06542.x", "meta_date_publication": "2011 Jan", "meta_volume": "26 Suppl 1", "meta_issue": "", "meta_pages": "96-101", "score": 50050.84, "text_hl": "Whether life style modification such as weight reduction or adding an @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@ reducing agent such as @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ or @CHEMICAL_Thiazolidinediones @CHEMICAL_MESH:D045162 @@@thiazolidinediones@@@ combined with current standard peginterferon plus @CHEMICAL_Ribavirin @CHEMICAL_MESH:D012254 @@@ribavirin@@@ treatment will benefit to the @<m>DISEASE_Hepatitis_C_Chronic</m> @DISEASE_MESH:D019698 @@@chronic hepatitis C@@@ @SPECIES_9606 @@@patients@@@ with @DISEASE_Fatty_Liver @DISEASE_MESH:D005234 @@@hepatic steatosis@@@ deserves further evaluation.", "citations": {"NLM": "Hwang SJ, Lee SD. Hepatic steatosis and hepatitis C: Still unhappy bedfellows? J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1():96-101. PMID: 21199519", "BibTeX": "@article{21199519, title={Hepatic steatosis and hepatitis C: Still unhappy bedfellows?}, author={Hwang SJ and Lee SD}, journal={J Gastroenterol Hepatol}, volume={26 Suppl 1}, pages={96-101}}"}}]}